Health Condition 1: E669- Obesity, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients present with classical signs and symptom of Sthoulya 2. BMI 25kg/m2 to 35kg/m2 will be selected for the study. 3. WHR i.e., Waist Hip Circumference ratio >0.95 in males and >0.8 in females will be selected. 4. Obesity-associated dis-lipidemic patients included in the study.
Exclusion criteria
Exclusion criteria: 1. BMI below 25kg/m2 and above 35kg/m2 are excluded. 2. Pregnancy and lactation 3. Obesity secondary to or associated with hypothyroidism,hypertension,diabetes mellitus, Cushing syndrome and other endocrine disorders. 4. Patients suffering from psychiatric illness are excluded. 5. Any concomitant serious disorders of liver, kidneys, heart, lungs or other organs. 6. Patient undergoing treatment for any other serious illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Development of Standard Manufacturing Process of Agnimantha patra swarasa and twaka kwatha bhavita Shilajatu. 2. Evaluation of clinical efficacy of Agnimantha patra swarasa and twaka kwatha bhavita Shilajatu in Sthoulya (Obesity) by determining classical symptoms, biochemical parameters and 7.5% reduction in weight.Timepoint: The time of assessment will be as follows: For objective criteria:baseline(0th day),60th day. For subjective criteria:baseline(0th day),15thday, 30th day,45thday,60th day and follow up on 90th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Development of preliminary analytical profile of Agnimantha patra swarasa and twaka kwatha bhavita Shilajatu.Timepoint: It will take 6months to assess analytical profile of drug | — |
Countries
India
Contacts
ALL INDIA INSTITUTE OF AYURVEDA 11007